Search filters

List of works by Kayleigh J Mason

A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis

scientific article published on 02 July 2019

Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR

scholarly article by Kayleigh J Mason et al published 1 May 2018 in JAMA Dermatology

Cumulative exposure to biologics and risk of cancer in psoriasis patients: A meta-analysis of Psonet studies from Israel, Italy, Spain, United Kingdom and Republic of Ireland.

scientific article published on 3 May 2018

Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy

scientific article published on 15 January 2019

Differential Drug Survival of Second-Line Biologic Therapies In Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

scientific article

Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

scientific article published on 02 March 2020

Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic

scientific article published on 29 April 2020

HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis

scientific article published on 20 December 2018

Identification of factors that may influence the selection of first-line biological therapy for people with psoriasis: a prospective, multicentre cohort study.

scientific article published on 07 April 2017

Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study

scientific article published on 28 August 2018

Persistence and effectiveness of nonbiologic systemic therapies for moderate-to-severe psoriasis in adults: a systematic review

scientific article published on 27 March 2019

Psychosocial factors partially mediate the relationship between mechanical hyperalgesia and self-reported pain

scientific article published on 01 January 2018

Risk of Cancer in Patients with Psoriasis on Biologic Therapies: A Systematic Review.

scientific article published on 19 July 2017

Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study

scientific article published on 19 November 2019

The British Association of Dermatologists Biologics and Immunomodulators Register: a centenary celebration of research collaboration in British dermatology

scientific article published on 01 December 2020